Gralidon

Medicinal product

(Invented) name

Gralidon

Active substance (s)

Anagrelidas

Strength

0,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX35, Anagrelide

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2018-11-29

Date of renewal

Documents

4295_1 pakuotes lapelis_2018-11-29.docx

4295_1 Gralidon_DC.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

EE/H/0255/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Anagrelidas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100573	86683	1086683	buteliukas	N100		Receptinis	LT/1/18/4295/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-10-28	Išregistruotas
2018-11-29	Registruotas